Tristetraprolin inhibits macrophage IL-27-induced activation of antitumour cytotoxic T cell responses.

about

Tristetraprolin inhibits macrophage IL-27-induced activation of antitumour cytotoxic T cell responses.

Item

http://www.wikidata.org/entity/Q41918691

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Tristetraprolin inhibits macro ...... ur cytotoxic T cell responses.

@en

type

Item

label

Tristetraprolin inhibits macro ...... ur cytotoxic T cell responses.

@en

prefLabel

Tristetraprolin inhibits macro ...... ur cytotoxic T cell responses.

@en

P1476

Tristetraprolin inhibits macro ...... ur cytotoxic T cell responses.

@en

P2093

Daniel F Hoft

http://www.w3.org/2001/XMLSchema#string

Huan Ning

http://www.w3.org/2001/XMLSchema#string

Hui Peng

http://www.w3.org/2001/XMLSchema#string

Jianguo Liu

http://www.w3.org/2001/XMLSchema#string

Lin Wei

http://www.w3.org/2001/XMLSchema#string

Qinghong Wang

http://www.w3.org/2001/XMLSchema#string

Rong Hou

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA.

Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development

Interleukin-27 in T cell immunity

Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay

Tristetraprolin binds to the 3'-untranslated region of cyclooxygenase-2 mRNA. A polyadenylation variant in a cancer cell line lacks the binding site

Cancer immunoediting: from immunosurveillance to tumor escape

A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency

Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover

Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression.

IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors.

P2888

s41467-017-00892-y

P304

867

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41467-017-00892-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092102035

http://www.w3.org/2001/XMLSchema#string

P698

29021521

http://www.w3.org/2001/XMLSchema#string

P932

5636828

http://www.w3.org/2001/XMLSchema#string